Literature DB >> 29157967

The Role of Interferon in Persistent Viral Infection: Insights from Murine Norovirus.

Timothy J Nice1, Bridget A Robinson2, Jacob A Van Winkle2.   

Abstract

Persistent viral infections result from evasion or avoidance of sterilizing immunity, extend the timeframe of virus transmission, and can trigger disease. Prior studies in mouse models of persistent infection have suggested that ineffective adaptive immune responses are necessary for persistent viral infection. However, recent work in the murine norovirus (MNV) model of persistent infection demonstrates that innate immunity can control both early and persistent viral replication independently of adaptive immune effector functions. Interferons (IFNs) are central to the innate control of persistent MNV, apart from a role in modulating adaptive immunity. Furthermore, subtypes of IFN play distinct tissue-specific roles in innate control of persistent MNV infection. Type I IFN (IFN-α/β) controls systemic replication, and type III IFN (IFN-λ) controls MNV persistence in the intestinal epithelium. In this article, we review recent findings in the MNV model, highlighting the role of IFNs and innate immunity in clearing persistent viral infection, and discussing the broader implications of these findings for control of persistent human infections.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29157967      PMCID: PMC5957778          DOI: 10.1016/j.tim.2017.10.010

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  127 in total

1.  Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice.

Authors:  A R Thomsen; J Johansen; O Marker; J P Christensen
Journal:  J Immunol       Date:  1996-10-01       Impact factor: 5.422

2.  Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection.

Authors:  Megan T Baldridge; Timothy J Nice; Broc T McCune; Christine C Yokoyama; Amal Kambal; Michael Wheadon; Michael S Diamond; Yulia Ivanova; Maxim Artyomov; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

Review 3.  The CD300 molecules: an emerging family of regulators of the immune system.

Authors:  Francisco Borrego
Journal:  Blood       Date:  2013-01-04       Impact factor: 22.113

4.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

5.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

Review 6.  Interferon-stimulated genes and their antiviral effector functions.

Authors:  John W Schoggins; Charles M Rice
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

Review 7.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

8.  Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8⁺ T-cell exhaustion.

Authors:  Myeong Sup Lee; Chan Hee Park; Yun Hee Jeong; Young-Joon Kim; Sang-Jun Ha
Journal:  PLoS Pathog       Date:  2013-07-18       Impact factor: 6.823

9.  Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains.

Authors:  Shu Zhu; Doron Regev; Makiko Watanabe; Danielle Hickman; Nissin Moussatche; Desyree Murta Jesus; Shannon M Kahan; Sawsan Napthine; Ian Brierley; Robert N Hunter; Divya Devabhaktuni; Melissa K Jones; Stephanie M Karst
Journal:  PLoS Pathog       Date:  2013-09-05       Impact factor: 6.823

10.  Norovirus antagonism of B-cell antigen presentation results in impaired control of acute infection.

Authors:  S Zhu; M K Jones; D Hickman; S Han; W Reeves; S M Karst
Journal:  Mucosal Immunol       Date:  2016-03-23       Impact factor: 7.313

View more
  15 in total

1.  Persistence of Systemic Murine Norovirus Is Maintained by Inflammatory Recruitment of Susceptible Myeloid Cells.

Authors:  Jacob A Van Winkle; Bridget A Robinson; A Mack Peters; Lena Li; Ruth V Nouboussi; Matthias Mack; Timothy J Nice
Journal:  Cell Host Microbe       Date:  2018-11-01       Impact factor: 21.023

Review 2.  Type III IFNs: Beyond antiviral protection.

Authors:  Sergei V Kotenko; Amariliz Rivera; Dane Parker; Joan E Durbin
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

3.  Selective Interferon Responses of Intestinal Epithelial Cells Minimize Tumor Necrosis Factor Alpha Cytotoxicity.

Authors:  Jacob A Van Winkle; David A Constant; Lena Li; Timothy J Nice
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

Review 4.  Interferon-λ orchestrates innate and adaptive mucosal immune responses.

Authors:  Liang Ye; Daniel Schnepf; Peter Staeheli
Journal:  Nat Rev Immunol       Date:  2019-06-14       Impact factor: 53.106

5.  A systematic approach to the development of a safe live attenuated Zika vaccine.

Authors:  Swee Sen Kwek; Satoru Watanabe; Kuan Rong Chan; Eugenia Z Ong; Hwee Cheng Tan; Wy Ching Ng; Mien T X Nguyen; Esther S Gan; Summer L Zhang; Kitti W K Chan; Jun Hao Tan; October M Sessions; Menchie Manuel; Julien Pompon; Camillus Chua; Sharifah Hazirah; Karl Tryggvason; Subhash G Vasudevan; Eng Eong Ooi
Journal:  Nat Commun       Date:  2018-03-12       Impact factor: 14.919

6.  Caspase-mediated cleavage of murine norovirus NS1/2 potentiates apoptosis and is required for persistent infection of intestinal epithelial cells.

Authors:  Bridget A Robinson; Jacob A Van Winkle; Broc T McCune; A Mack Peters; Timothy J Nice
Journal:  PLoS Pathog       Date:  2019-07-22       Impact factor: 6.823

Review 7.  Norovirus antivirals: Where are we now?

Authors:  Natalie E Netzler; Daniel Enosi Tuipulotu; Peter A White
Journal:  Med Res Rev       Date:  2018-12-25       Impact factor: 12.944

Review 8.  Virus-Bacteria Interactions: Implications and Potential for the Applied and Agricultural Sciences.

Authors:  Matthew D Moore; Lee-Ann Jaykus
Journal:  Viruses       Date:  2018-02-02       Impact factor: 5.048

9.  Ifit1 regulates norovirus infection and enhances the interferon response in murine macrophage-like cells.

Authors:  Harriet V Mears; Edward Emmott; Yasmin Chaudhry; Myra Hosmillo; Ian G Goodfellow; Trevor R Sweeney
Journal:  Wellcome Open Res       Date:  2019-05-15

10.  Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion.

Authors:  Achille Broggi; Francesca Granucci; Ivan Zanoni
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.